What can I expect after stopping Latuda (lurasidone) after 13 days of use?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 2, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

What to Expect 13 Days After Stopping Latuda

After 13 days off Latuda (lurasidone), most acute discontinuation symptoms should be resolving or have already resolved, though you may still experience some lingering effects depending on how the medication was stopped and your individual circumstances.

Timeline and Expected Symptoms

Acute Phase (Days 1-7)

The most intense withdrawal effects typically occur within the first week after stopping an antipsychotic. Based on guideline evidence, abrupt discontinuation of antipsychotics can cause dyskinesias, parkinsonian symptoms, dystonias, and in rare cases, neuroleptic malignant syndrome 1. However, research specifically on lurasidone suggests that symptoms may not worsen to a clinically meaningful degree after short-term discontinuation up to 3 weeks 2.

Where You Are Now (Day 13)

At 13 days post-discontinuation:

  • Movement-related symptoms: If you experienced akathisia (restlessness), tremor, or muscle stiffness while on Latuda, these may be improving or resolved. Conversely, some patients develop withdrawal-emergent movement disorders that should be monitored 1.

  • Psychiatric symptoms:

    • If Latuda was treating bipolar depression, there is a risk of mood destabilization, including potential emergence of manic or hypomanic symptoms 3, 4
    • If treating schizophrenia, psychotic symptoms may gradually return, though research shows minimal worsening in the first 2-3 weeks 2
    • Anxiety, irritability, or sleep disturbances may persist 3
  • Physical symptoms: Nausea, which is common with lurasidone, should have resolved. Any metabolic changes (blood sugar, weight) begin stabilizing 3.

Critical Monitoring Points

Watch for these concerning symptoms that require immediate medical attention:

  • Signs of neuroleptic malignant syndrome: high fever, confusion, severe muscle rigidity, changes in breathing or heart rate, excessive sweating 3
  • Suicidal thoughts or severe mood changes 3, 5
  • New or worsening involuntary movements (tardive dyskinesia can emerge after stopping) 1, 3
  • Manic symptoms: decreased need for sleep (1-2 hours/night), elevated mood, increased energy, impulsive behavior 4

Method of Discontinuation Matters

The way Latuda was stopped significantly impacts what you're experiencing:

  • Abrupt discontinuation: Guidelines strongly recommend against this approach 1. If you stopped suddenly, you're more likely to have experienced withdrawal symptoms in the first week, which should now be improving.

  • Gradual taper: If tapered over more than 1 month as recommended 1, you should have minimal to no withdrawal symptoms at day 13.

Research on lurasidone specifically found that the strategy of discontinuation (abrupt vs. gradual) and duration did not significantly affect symptom changes in acute schizophrenia patients 2, though this may not apply to all clinical situations.

What Happens Next

Beyond day 13:

  • Most acute withdrawal effects from antipsychotics resolve within 2-4 weeks of discontinuation
  • The underlying condition being treated (bipolar depression or schizophrenia) will determine longer-term trajectory
  • Without treatment, symptoms of the original illness typically re-emerge gradually over weeks to months
  • Some patients report feeling better off medication, while others experience symptom return 1

Common Pitfalls to Avoid

  1. Mistaking withdrawal for illness relapse: Increased anxiety, sleep problems, or restlessness at this point could be either withdrawal effects or early signs of illness recurrence. Close monitoring with your prescriber is essential.

  2. Ignoring metabolic improvements: If you experienced weight gain or metabolic issues on Latuda, these should be improving. Don't assume all symptoms are withdrawal-related.

  3. Lack of follow-up: Even if you feel fine at day 13, continued monitoring is crucial as psychiatric symptoms may emerge later 3.

You should be in close contact with your prescribing physician at this point to assess whether alternative treatment is needed and to monitor for illness recurrence.

Related Questions

How long does antipsychotic withdrawal last when lurasidone (Latuda) is stopped abruptly?
After stopping Latuda (lurasidone) abruptly after 22 days, when can I expect my neurological function to return to normal?
What symptoms can be expected on day 11 after discontinuing Latuda (lurasidone)?
Why am I unable to concentrate after abruptly stopping lurasidone (Latuda) 40 mg 17 days ago?
How long does agitation persist after discontinuing lurasidone (Latuda)?
What is the recommended cefoperazone‑sulbactam (Cefosulb) dosing for acute pyelonephritis in adults, including adjustments for renal impairment?
What is the recurrence rate of common bile duct stone obstruction after prior clearance, and what symptoms suggest a recurrent blockage?
What is the prognosis and expected survival for a 30‑year‑old Black male, 6'5" tall, weighing 318 lb, with hypertension treated with amlodipine, normal complete blood count and comprehensive metabolic panel, normal renal function, mildly elevated troponin, normal electrocardiogram, negative chest X‑rays, periventricular white‑matter changes on brain MRI, high‑titer anti‑RNP antibodies, elevated creatine kinase, G6PD deficiency, and pending sleep‑apnea and Cushing‑syndrome evaluations, and what findings might the upcoming electromyography (EMG) reveal?
What are the differential diagnoses on chest radiograph for subsegmental atelectasis versus early pulmonary fibrosis?
What is the most likely diagnosis and initial management for a patient with normocytic anemia, lymphopenia, monocytosis, mild coagulopathy, metabolic acidosis, renal insufficiency, low albumin, mildly elevated bilirubin, and markedly elevated NT‑proBNP and troponin levels?
What is an appropriate pain management regimen for a patient who had an above‑knee amputation two months ago, is experiencing phantom limb pain, and is currently taking aspirin and rivaroxaban (Xarelto)?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.